SOURCE: Amedica Corporation

Amedica Corporation

August 01, 2016 12:38 ET

Amedica Corporation to Release Second Quarter 2016 Financial Results and Host Conference Call

SALT LAKE CITY, UT--(Marketwired - Aug 1, 2016) -  Amedica Corporation (NASDAQ: AMDA), a company that develops and commercializes silicon nitride ceramics as a biomaterial platform, announced today that it will release financial results for its second quarter 2016 on Thursday, August 11, 2016, after the market closes.

Following the release, that same day the Company will host a conference call and simultaneous audio webcast with Dr. Sonny Bal, Chairman and CEO of Amedica Corporation, as well as key members of the management team to review its second quarter 2016 financial results. Details related to this call are as follows:

Date: Thursday, August 11, 2016

Time: 5:00 p.m. Eastern Time

Conference ID: 13642503

Dial-in:  Toll-free 877-524-8416
 International 412-902-1028

Webcast: Investors section of the Company's website

For those who are not available to listen to the live webcast, a digital replay will be archived on the investor relations section of the Amedica website under Events & Presentations.

About Amedica Corporation
Amedica is focused on the development and application of medical-grade silicon nitride ceramics. Amedica markets spinal fusion products and is developing a new generation of wear- and corrosion-resistant implant components for hip and knee arthroplasty. The Company manufactures its products in its ISO 13485 certified manufacturing facility and, through its partnership with Kyocera, the world's largest ceramic manufacturer. Amedica's spine products are FDA-cleared, CE-marked, and are currently marketed in the U.S. and select markets in Europe and South America through its distributor network and its growing OEM partnerships.

For more information on Amedica or its silicon nitride material platform, please visit www.amedica.com.

Contact Information

  • Contacts:
    Mike Houston
    VP, Commercialization
    801-839-3534
    IR@amedica.com